Core Competency Module 9: Medication Procurement

Course Description 

This module provides participants with an overview of the medication procurement process as it relates to oncology pharmacy. Upon completion of this module, pharmacists will gain a working knowledge of process of medication procurement and the role of specialty pharmacy in the procurement pathway. 

This is knowledge-based on-demand webinar for Hematology/Oncology pharmacists, and it’s approved for 1.00 CE hours under the ACPE universal activity number # 0465-0000-20-095-H04-P. 

Please note: This module is also included in the Core Competency Certificate Program bundle but can be purchased independently.

Joseph A. Kalis PharmD, BCOP 
Ambulatory Oncology Clinical Specialist at UCHealth in Colorado Springs  
(Relevant financial relationships include Abbvie/Genentech (Advisory Board Member/Consultant), Amgen (Advisory Board Member/Consultant), Takeda (Advisory Board Member/Consultant), Tesaro (Speaker Bureau)) 

Dr. Joseph A. Kalis is an Ambulatory Oncology Clinical Specialist with UCHealth Memorial Hospital in Colorado Springs, CO, where he is part of a large community oncology practice. His passion is helping patients become fully invested and engaged in their cancer care. The role of “pharmacist-as-educator” is central to his practice. Dr Kalis believes that education is most effective when approached with a philosophy of collegiality. His professional interests include novel cancer treatments, bow ties, and Sasquatch. 

System Requirements  

This on-demand webinar requires a computer and a reliable internet connection. 

If you have questions about this module, please contact HOPA Education at EducationSupport@hoparx.org. 

Accreditation Statement 

The Hematology/Oncology Pharmacy Association (HOPA) is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. A statement of credit will be issued only upon completion of the post-activity evaluation form and post-test. ACPE credit must be claimed by May 26, 2023. 

Disclosure of Conflicts of Interest 

The Hematology/Oncology Pharmacy Association (HOPA) assesses conflict of interest with its instructors, planners, managers, and other individuals who are in a position to control the content of CE activities. All relevant conflicts of interest that are identified are thoroughly vetted by HOPA for fair balance, scientific objectivity of studies utilized in this activity, and patient care recommendations. HOPA is committed to providing its learners with high-quality CE activities and related materials that promote improvements of quality in healthcare and not a specific proprietary business interest of a commercial interest.